“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."
A trial looking at Taxoprexin (DHA-paclitaxel) for advanced breast cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial was looking at a drug called Taxoprexin for breast cancer that has spread to another part of the body (secondary breast cancer).
Doctors often use chemotherapy to treat breast cancer that has spread. In this trial, they were looking at a new drug called Taxoprexin. It is made up of a
The aims of the trial were to find out
- How well Taxoprexin worked for secondary breast cancer
- What the side effects were
Summary of results
The researchers presented the results of the trial at a large cancer conference in 2003. They found that Taxoprexin worked about as well as other taxane drugs.
- The trial recruited 38 women with advanced breast cancer
- In 7 of the women, the cancer got smaller – researchers call this a
- In 13 women, the cancer stayed the same size – researchers call this
- In 17 women, the cancer continued to grow
- They did not have results for one person
The main side effect was a drop in the number of blood cells, causing an increased risk of infection and bruising or bleeding problems.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Prof Stephen Johnston